Preirradiation chemotherapy with methotrexate, rituximab, and temozolomide and post-irradiaiton temozolomide for primary central nervous system lymphoma: RTOG 0227 phase II study results Conference

Glass, Jon, Won, Minhee, Schultz, Christopher J et al. (2013). Preirradiation chemotherapy with methotrexate, rituximab, and temozolomide and post-irradiaiton temozolomide for primary central nervous system lymphoma: RTOG 0227 phase II study results . JOURNAL OF CLINICAL ONCOLOGY, 31(15),

International Collaboration

cited authors

  • Glass, Jon; Won, Minhee; Schultz, Christopher J; Brat, Daniel; Bartlett, Nancy; Suh, John H; Fisher, Barbara Jean; Liepman, Marcia K; Mehta, Minesh P

sustainable development goals

authors

date/time interval

  • May 31, 2013 -

publication date

  • May 20, 2013

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • Chicago, IL

Conference

  • 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

volume

  • 31

issue

  • 15